NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways

Detalles Bibliográficos
Autores principales: Honda, Ayumi, Kuramoto, Kazuya, Niwa, Tomoko, Naito, Haruna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018113/
https://www.ncbi.nlm.nih.gov/pubmed/29941953
http://dx.doi.org/10.1038/s41408-018-0098-z
_version_ 1783334884029235200
author Honda, Ayumi
Kuramoto, Kazuya
Niwa, Tomoko
Naito, Haruna
author_facet Honda, Ayumi
Kuramoto, Kazuya
Niwa, Tomoko
Naito, Haruna
author_sort Honda, Ayumi
collection PubMed
description
format Online
Article
Text
id pubmed-6018113
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60181132018-06-27 NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways Honda, Ayumi Kuramoto, Kazuya Niwa, Tomoko Naito, Haruna Blood Cancer J Correspondence Nature Publishing Group UK 2018-06-25 /pmc/articles/PMC6018113/ /pubmed/29941953 http://dx.doi.org/10.1038/s41408-018-0098-z Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Honda, Ayumi
Kuramoto, Kazuya
Niwa, Tomoko
Naito, Haruna
NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways
title NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways
title_full NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways
title_fullStr NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways
title_full_unstemmed NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways
title_short NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways
title_sort ns-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the jak2 and src signaling pathways
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018113/
https://www.ncbi.nlm.nih.gov/pubmed/29941953
http://dx.doi.org/10.1038/s41408-018-0098-z
work_keys_str_mv AT hondaayumi ns018reducesmyelomacellproliferationandsuppressesosteolysisthroughinhibitionofthejak2andsrcsignalingpathways
AT kuramotokazuya ns018reducesmyelomacellproliferationandsuppressesosteolysisthroughinhibitionofthejak2andsrcsignalingpathways
AT niwatomoko ns018reducesmyelomacellproliferationandsuppressesosteolysisthroughinhibitionofthejak2andsrcsignalingpathways
AT naitoharuna ns018reducesmyelomacellproliferationandsuppressesosteolysisthroughinhibitionofthejak2andsrcsignalingpathways

Ejemplares similares